Karnataka opens detention centre for illegal immigrants

Mangalore, Feb 17: The Popular Front of India (PFI) on Monday took out a march in Mangalore's Deralakatte without seeking permission, police said.

"They were only given permission for a programme but they took out a march from Madaninagar to Deralakatte," said ACP Kodanada Rama.

Bengaluru, Mar 6: Karnataka home minister Basavaraj Bommai on Friday said he has asked police to enhance the security of Congress leaders and former ministers UT Khader and Tanveer Sait.

"Threat perception has been there for some time now, all the more after the attack on Tanveer Sait. Their (Congress MLAs UT Khader and Tanveer Sait) security is necessary. I have intimidated them. I have asked police to enhance their security," Bommai told media persons.

"After the assault on Tanveer Sait, the police told me that there were some intelligence reports and asked to me to take proper security. They have given one police man for the name's sake," Khader said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.